Literature DB >> 17332445

Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials.

Alexander C Flint1, Gary R Duckwiler, Ronald F Budzik, David S Liebeskind, Wade S Smith.   

Abstract

BACKGROUND AND
PURPOSE: Acute stroke from occlusion of the intracranial internal carotid artery (ICA) generally has a poor prognosis and appears to respond poorly to intravenous thrombolysis. Mechanical thrombectomy is a newly available modality for acute stroke therapy, but it is unknown whether this endovascular therapy may have a role in the specific setting of intracranial ICA occlusion. We therefore assessed the success rate of the Merci Retriever mechanical thrombectomy device in recanalization of intracranial ICA occlusions and sought to determine whether ICA recanalization with this therapy can result in better outcomes.
METHODS: All patients with acute stroke from intracranial ICA occlusion were identified in the MERCI and Multi MERCI Part I trials. We determined the success rate of ICA recanalization with endovascular thrombectomy and then assessed clinical outcomes according to whether vessel recanalization was successful.
RESULTS: Eighty patients with acute stroke from intracranial ICA occlusion were identified. Of these 80 patients, 53% had successful ICA recanalization with the Merci Retriever alone and 63% had ICA recanalization with use of the Merci Retriever plus adjunctive endovascular treatment. Baseline patient characteristics and procedural complications did not differ between the recanalized and nonrecanalized groups. Good clinical outcome, defined by a modified Rankin Scale of 0 to 2 at 90 days, occurred in 39% of patients with ICA recanalization (n=19 of 49) and in 3% of patients without ICA recanalization (n=1 of 30) (P<0.001; one patient was lost to follow up for 90-day modified Rankin Scale). Ninety-day mortality was 30% (n=15 of 50) in the recanalized group and 73% (n=22 of 30) in the nonrecanalized group (P<0.001). Symptomatic hemorrhage was not significantly different between the recanalized (6% [n=3 of 50]) and nonrecanalized (16.7% [n=5 of 30]) groups (P=0.14). Hemorrhage rates were also not found to be influenced by use of intravenous thrombolysis before mechanical thrombectomy. Multivariable logistic regression identified ICA recanalization (OR=28.4, 95% CI=2.6 to >99.9) and lack of history of hypertension (OR=0.15, 95% CI=0.04 to 0.57) as significant predictors of a good 90-day outcome. Failure to recanalize the ICA (OR=0.16, 95% CI=0.05 to 0.51) and age (per decade, OR=1.07, 95% CI=1.03 to 1.13) were significant predictors of mortality at 90 days.
CONCLUSIONS: Mechanical thrombectomy of acute intracranial ICA occlusion using the Merci Retriever device, alone or in combination with adjunctive endovascular therapy, has a high rate of successful vessel recanalization. Subjects with successful ICA recanalization by this method have improved poststroke clinical outcome and survival compared with subjects in which the ICA is not successfully recanalized.

Entities:  

Mesh:

Year:  2007        PMID: 17332445     DOI: 10.1161/01.STR.0000260187.33864.a7

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  57 in total

1.  Is mechanical clot removal or disruption a cost-effective treatment for acute stroke?

Authors:  M N Nguyen-Huynh; S C Johnston
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

2.  Multimodal reperfusion therapy for large hemispheric infarcts in octogenarians: is good outcome a realistic goal?

Authors:  D Arkadir; R Eichel; J M Gomori; T Ben Hur; J E Cohen; R R Leker
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

3.  Considerations about Occlusion of the Intracranial Distal Internal Carotid Artery.

Authors:  G B Bradac; F Venturi; G Stura; M Coriasco; G Ventilii; D Garabello; M Bergui
Journal:  Clin Neuroradiol       Date:  2015-11-24       Impact factor: 3.649

4.  Incomplete mechanical recanalization of middle cerebral artery occlusions facilitates endogenous recanalization within 5 h.

Authors:  Yince Loh; Zhongsong Shi; David Liebeskind; Reza Jahan; Nestor Gonzalez; Paul M Vespa; Sidney Starkman; Jeffrey L Saver; Satoshi Tateshima; Fernando Vinuela; Gary Duckwiler
Journal:  J Neurointerv Surg       Date:  2012-02-07       Impact factor: 5.836

Review 5.  Endovascular therapy in hyperacute ischaemic stroke: history and current status.

Authors:  Alex M Mortimer; Marcus D Bradley; Shelley A Renowden
Journal:  Interv Neuroradiol       Date:  2013-12-18       Impact factor: 1.610

6.  Clotting factors to treat thrombolysis-related symptomatic intracranial hemorrhage in acute ischemic stroke.

Authors:  Yazan J Alderazi; Niravkumar V Barot; Hui Peng; Farhaan S Vahidy; Digvijaya D Navalkele; Navdeep Sangha; Vivek Misra; Sean I Savitz
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-12-08       Impact factor: 2.136

7.  Basilar artery occlusion following C1 lateral mass fracture managed by mechanical and pharmacological thrombolysis.

Authors:  Patrick A Sugrue; Ziad A Hage; Daniel L Surdell; Mina Foroohar; John Liu; Bernard R Bendok
Journal:  Neurocrit Care       Date:  2008-10-28       Impact factor: 3.210

8.  Adjuvant revascularization of intracranial artery occlusion with angioplasty and/or stenting.

Authors:  Jin Woo Choi; Jae Kyun Kim; Byung Se Choi; Jeoung Hyun Kim; Hae Jun Hwang; Jong Sung Kim; Sang Joon Kim; Dae Chul Suh
Journal:  Neuroradiology       Date:  2008-09-26       Impact factor: 2.804

9.  Impact of Merci device fracture on clinical outcome of acute ischemic stroke after mechanical thrombectomy.

Authors:  Zhong-Song Shi; Gary R Duckwiler; Yince Loh; David S Liebeskind; Nestor R Gonzalez; Satoshi Tateshima; Reza Jahan; Jeffrey L Saver; Fernando Viñuela
Journal:  CNS Neurosci Ther       Date:  2012-08-20       Impact factor: 5.243

10.  Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA.

Authors:  Wade S Smith; Michael H Lev; Joey D English; Erica C Camargo; Maggie Chou; S Claiborne Johnston; Gilberto Gonzalez; Pamela W Schaefer; William P Dillon; Walter J Koroshetz; Karen L Furie
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.